Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 32 for “"Tumor dormancy"”.

  1. Identifying Epigenetic Regulators Of Tumor Dormancy And Recurrence

    … largely due tometastatic recurrence. Recurrent tumors arise from residual tumor cells, which can survive cancer therapy and stay dormant for an extended period of time. Despite their clinical importance, the biology of tumor dormancy and recurrence are poorly understood. Using a HER2 inducible …

    penn Repository record for Identifying Epigenetic Regulators Of Tumor Dormancy And Recurrence (opens in a new tab)

  2. TUMOR-INTRINSIC INFLAMMATORY PATHWAYS ASSOCIATED WITH TUMOR DORMANCY AND RECURRENCE

    … of breast cancer is limited due to a fraction of tumor cells escaping drug-treatment by entering a dormant state, only to relapse years or decades later at distant sites. Host-driven chronic inflammatory cells such as M2 macrophages play an important role in tumorigenesis, but the role of …

    vcu Repository record for TUMOR-INTRINSIC INFLAMMATORY PATHWAYS ASSOCIATED WITH TUMOR DORMANCY AND RECURRENCE (opens in a new tab)

  3. Mechanisms of tumor dormancy and awakening in the lymph node

    Mechanisms of tumor dormancy are being systematically uncovered through the major organs. Yet little is known about lymph nodes (LNs) as harbors of residual disease, despite their well-established prognostic significance for metastasis and direct contribution to metastasis in visceral organs. …

    washington Repository record for Mechanisms of tumor dormancy and awakening in the lymph node (opens in a new tab)

  4. A Theoretical Model Of Breast Tumor Metastases In The Context Of Tumor Dormancy

    … considered as a late event in the primary tumor process. Recent evidence suggests that tumor cells dissemination may occur when the tumor is at a size that does not normally warrant a systemic treatment. Current breast cancer models developed as part of the Cancer Intervention and …

    umn Repository record for A Theoretical Model Of Breast Tumor Metastases In The Context Of Tumor Dormancy (opens in a new tab)

  5. Analysis of chemotherapeutic-induced tumor dormancy in Glioblastoma Multiforme and alternative therapy approaches

    … Multiforme is a malignant, primary brain tumor. Its incurability relies on the ability of the tumor to evade therapy and develop recurrences. Due to the impeded transport of molecules across the blood-brain barrier (BBB), subletal doses of agents within the tumor result in …

    cau-kiel Repository record for Analysis of chemotherapeutic-induced tumor dormancy in Glioblastoma Multiforme and alternative therapy approaches (opens in a new tab)

  6. Examining the Role of Regulatory Lymphocytes in a Mouse Model of BCL1 Tumor Dormancy

    Cancer dormancy is a clinical state where residual tumor cells persist for long periods but do not cause detectable disease. However, tumor regrowth can occur and is accompanied by resistance to treatment and high mortality rates. The mechanisms that mediate tumor dormancy have been studied using …

    utswmed Repository record for Examining the Role of Regulatory Lymphocytes in a Mouse Model of BCL1 Tumor Dormancy (opens in a new tab)

  7. Determining the Role of Autophagy in HER2/neu-Induced Mammary Tumor Dormancy and Recurrence

    … from breast cancer is principally due to tumor recurrence. Recurrent breast cancers arise from the pool of residual tumor cells, termed minimal residual disease, that survive treatment and may exist in a dormant state for up to 20 years following treatment of the primary tumor. As …

    penn Repository record for Determining the Role of Autophagy in HER2/neu-Induced Mammary Tumor Dormancy and Recurrence (opens in a new tab)

  8. Preconditioning of the tumor microenvironment by means of low dose chemotherapies for an effective immunotherapy of breast cancer

    … recurrence of the disease arising from dormant tumor cells established by cancer therapies. Patients who initially respond to cancer therapies often succumb to distant recurrence of the disease. It is not clear why people with the same type of breast cancer respond to treatments differently; …

    vcu Repository record for Preconditioning of the tumor microenvironment by means of low dose chemotherapies for an effective immunotherapy of breast cancer (opens in a new tab)

  9. Treatment-Induced Breast Cancer Dormancy and Relapse

    When breast tumor cells encounter stress due to cancer therapies, they may enter a dormant state, escaping from treatment-induced apoptosis. Dormant cells may eventually regain proliferative capabilities and cause recurrent metastatic disease, which is the leading cause of mortality in breast …

    vcu Repository record for Treatment-Induced Breast Cancer Dormancy and Relapse (opens in a new tab)

  10. Developing 3D Engineered in Vitro Models to Study the Impact of Brain Microenvironment Derived Cues and Chemotherapy Drugs on Dormancy in Brain Metastatic Breast Cancer

    … lymphnodes) to develop secondary (metastatic) tumors. Upon arriving in the secondary organ, disseminated tumor cells (DTCs) exhibit dormancy to evade cell death and gain therapeutic resistance via tumor microenvironment-derived biomechanical, cellular and/or bio-chemical cues. Metastatic breast …

    alabama Repository record for Developing 3D Engineered in Vitro Models to Study the Impact of Brain Microenvironment Derived Cues and Chemotherapy Drugs on Dormancy in Brain Metastatic Breast Cancer (opens in a new tab)

  11. ASSESSMENT OF FLEXIBLE TECHNIQUES FOR MODELING THE HAZARD FUNCTION IN THE ANALYSIS OF SURVIVAL DATA

    … in several data sets for various kinds of tumor, for example breast cancer, have found an interpretation in the context of tumor dormancy theory. To model such possibly complex patterns sufficiently flexible techniques are required. This thesis work compares in the homogenous case the …

    milano Repository record for ASSESSMENT OF FLEXIBLE TECHNIQUES FOR MODELING THE HAZARD FUNCTION IN THE ANALYSIS OF SURVIVAL DATA (opens in a new tab)

  12. Understanding the Metabolic and Genetic Regulation of Breast Cancer Recurrence Using Magnetic Resonance-Based Integrative Metabolomics

    … from this disease. The mechanisms underlying tumor recurrence remain largely unknown. To dissect those mechanisms, our laboratory has developed inducible transgenic mouse models that accurately recapitulate key features of the natural history of human breast cancer progression: primary tumor …

    penn Repository record for Understanding the Metabolic and Genetic Regulation of Breast Cancer Recurrence Using Magnetic Resonance-Based Integrative Metabolomics (opens in a new tab)

  13. Kiss1 Metastasis Suppressor Secretion Is Required For Metastasis Suppression

    … at the secondary site. More importantly, the dormancy of C8161.9KFM cells was sustained providing a significant survival advantage in these mice when compared to mice receiving C8161.9vector controls. These data indicate that KISS1 secretion is required for multiple organ metastasis …

    uab Repository record for Kiss1 Metastasis Suppressor Secretion Is Required For Metastasis Suppression (opens in a new tab)

  14. Method development for identification of targetable genes in ADT-induced prostate cancer dormancy : the case of Interleukin-33

    … a response but often leads to ADT-induced dormancy that precedes relapse to castration-resistant PCa, which is incurable. This underscores the need to better understand tumor dormancy, identify critical genes for dormant cell survival, and develop therapies to target cancer in the earlier …

    ubc Repository record for Method development for identification of targetable genes in ADT-induced prostate cancer dormancy : the case of Interleukin-33 (opens in a new tab) Download PDF for Method development for identification of targetable genes in ADT-induced prostate cancer dormancy : the case of Interleukin-33 (opens in a new tab)

  15. The Role of The Diras Family Members In Regulating Ras Function, Cancer Growth and Autophagy

    DIRAS3 is a maternally imprinted tumor suppressor gene that is downregulated by multiple mechanisms across several tumor types. When re-expressed, DIRAS3 decreases proliferation, inhibits motility, and induces autophagy and tumor dormancy. DIRAS3 encodes a 26 kDa small GTPase with 60% homology to …

    uthsc Repository record for The Role of The Diras Family Members In Regulating Ras Function, Cancer Growth and Autophagy (opens in a new tab)

  16. 3D Engineered Biomimetic Models to Study Mechanisms of Cancer Metastasis

    … immunotherapy, we reversed pro-tumoral immune activation, increased chemotherapy sensitivity and reduced ovarian cancer metastatic colonization. Lastly, to demonstrate the power of the dECM model for discovery of molecular mechanisms, we pivoted to address the critical clinical …

    tamu Repository record for 3D Engineered Biomimetic Models to Study Mechanisms of Cancer Metastasis (opens in a new tab) Embargoed until 2027-08-01

  17. 3D Engineered Biomimetic Models to Study Mechanisms of Cancer Metastasis

    … immunotherapy, we reversed pro-tumoral immune activation, increased chemotherapy sensitivity and reduced ovarian cancer metastatic colonization. Lastly, to demonstrate the power of the dECM model for discovery of molecular mechanisms, we pivoted to address the critical clinical …

    tamu Repository record for 3D Engineered Biomimetic Models to Study Mechanisms of Cancer Metastasis (opens in a new tab) Embargoed until 2027-08-01

  18. 3D Engineered Biomimetic Models to Study Mechanisms of Cancer Metastasis

    … immunotherapy, we reversed pro-tumoral immune activation, increased chemotherapy sensitivity and reduced ovarian cancer metastatic colonization. Lastly, to demonstrate the power of the dECM model for discovery of molecular mechanisms, we pivoted to address the critical clinical …

    tamu Repository record for 3D Engineered Biomimetic Models to Study Mechanisms of Cancer Metastasis (opens in a new tab) Embargoed until 2027-08-01

Page 1 of 2